Prostate in Medical News

Bellicum Pharmaceuticals Announces Initiation of Phase I/II Clinical Trial of Novel Vaccine for Patients With Advanced Prostate Cancer

HOUSTON, Aug. 6 /PRNewswire/ -- Bellicum Pharmaceuticals, Inc. today announced dosing of the first patient in a Phase I/II clinical trial of BP-GMAX-CD1, a novel pharmacologically regulated dendritic cell vaccine for the treatment of prostate cancer. The disease-specific trial is be...

Ferring Pharmaceuticals Announces Trade Name FIRMAGON(R) (degarelix for injection) for Advanced Prostate Cancer Treatment

PARSIPPANY, N.J., Aug. 4 /PRNewswire/ -- Ferring Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has approved the trade name FIRMAGON(R) (degarelix for injection) for its prostate cancer treatment previously marketed under the generic name degarelix. FIRMAGON...

New Spanish-Language Consumer Guides Compare Treatments for Depression, Prostate Cancer and Other Conditions

ROCKVILLE, Md., July 29 /PRNewswire-USNewswire/ -- Spanish speakers who want to know how soon they can expect to feel better when taking an antidepressant, which rheumatoid arthritis drugs work best against pain or how surgery compares with other options for prostate cancer n...

LSUHSC contributes to revealing targets to reduce racial disparity in prostate cancer deaths

New Orleans, LA The latest findings of the North Carolina-Louisiana Prostate Cancer Project reveal potential new targets for reducing racial disparities in prostate cancer survival and highlight the importance of the health care delivery system. The study reports differences in physician trust, ...

MEK4, genistein and invasion of human prostate cancer cells

Researchers have identified MEK4 as a pro-invasion protein and the target for genistein, a dietary compound, in prostate cancer cells, according to a new study published online July 28 in the Journal of the National Cancer Institute . Li Xu, M.D., Ph.D., and Raymond C. Bergan, M.D., of the Dep...

Surveyed Oncologists Expect to Prescribe Provenge to about Half of Their Prostate Cancer Patients if the Vaccine is Approved

WALTHAM, Mass., July 28 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, if Dendreon's Provenge receives regulatory approval, surveyed oncologists expect to prescribe Provenge to ...

Men Who Have Prostate Cancer Surgery Do Well

But study didn't determine value of any treatment vs. watchful waiting MONDAY, July 27 (HealthDay News) -- A major study has good news for men who have prostate cancer surgery but leaves unanswered the complicated question of whether a man should have that operation, another treatment...

Most Not Worried by Delayed Prostate Cancer Therapy

Little anxiety noted in survey of men who opt out of aggressive treatment MONDAY, July 27 (HealthDay News) -- Men who delay treatment for their early prostate cancer are not especially anxious about living with the disease, new Dutch research shows. The evidence seems to contradict...

Driven by Launch of Emerging Therapies, Overall Prostate Cancer Drug Market Will Increase by $2 Billion Through 2018

Emerging Therapies to Treat Metastatic Hormone-Refractory Prostate Cancer Will Capture More Than One-Third of the Market, According to a New Report from Decision Resources WALTHAM, Mass., July 27 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory f...

Study finds acceptable levels of anxiety among men living with early, untreated prostate cancer

Men with early stages of prostate cancer who delay radical treatment in favor of an approach of "expectant management" do not have high levels of anxiety and distress. That is the conclusion of a new study published in the September 1, 2009 issue of Cancer , a peer-reviewed journal of the America...

Scientists discover key event in prostate cancer progression

COLUMBUS, Ohio A study led by researchers at the Ohio State University Comprehensive Cancer Center and Dana-Farber Cancer Institute reveals how late-stage, hormone-independent prostate tumors gain the ability to grow without need of hormones. The onset of hormone-independent growth marks an ad...

Innovative Prostate Cancer Treatment Known as Sonablate(R) HIFU Now Available at Third Site in India

CHARLOTTE, N.C., July 17 /PRNewswire/ -- India High Intensity Focused Ultrasound Devices Private Limited (India HIFU), an affiliate of US HIFU -- a worldwide leader in the development, distribution and use of minimally invasive high intensity focused ultrasound (HIFU) technologies -- off...

Combination Therapy Best for Aggressive Prostate Cancer

Adding radiation and hormone treatment to brachytherapy improves survival, study shows MONDAY, July 13 (HealthDay News) -- Men with aggressive prostate cancer who have brachytherapy alone are more likely to die than those who receive a combination of treatments, new findings show. I...

Heavy Drinking Linked to Aggressive Prostate Cancer

Consumption also appears to undercut effect of cancer-prevention drug,, MONDAY, July 13 (HealthDay News) -- Heavy drinking, especially when it's beer, increases the risk for highly aggressive prostate cancer, a new study finds. The researchers did not set out to determine the effec...

'Comparative Effectiveness' Research Addresses Options for Treating Prostate Cancer

Dr. Randolph Says Bioidentical Testosterone Can Promote Prostate Health Jacksonville, Fla. (Vocus) July 8, 2009 -- On June 30th, the Institute of Medicine released a list of 100 priorities it recommends for "comparative effectiveness" research. Among the 10...

Purdue researchers create prostate cancer 'homing device' for drug delivery

WEST LAFAYETTE, Ind. - A new prostate cancer "homing device" could improve detection and allow for the first targeted treatment of the disease. A team of Purdue University researchers has synthesized a molecule that finds and penetrates prostate cancer cells and has created imaging agents and t...

Predicting the return of prostate cancer: New Johns Hopkins study betters the odds of success

Cancer experts at Johns Hopkins say a study tracking 774 prostate cancer patients for a median of eight years has shown that a three-way combination of measurements has the best chance yet of predicting disease metastasis. The new prediction method comprises the length of time it takes for PSA ...

Promising Therapy for Prostate Cancer

Experimental drug beat back inoperable cancer in two patients, study claims MONDAY, June 22 (HealthDay News) -- An experimental drug therapy appears to have helped destroy allegedly inoperable prostate cancer in two patients in a clinical trial. Use of the immunotherapeutic agent MD...

Mayo researchers: Dramatic outcomes in prostate cancer study

ROCHESTER, Minn. -- Two Mayo Clinic patients whose prostate cancer had been considered inoperable are now cancer free thanks in part to an experimental drug therapy that was used in combination with standardized hormone treatment and radiation therapy. The men were participating in a clinical tr...

Green Tea Component May Slow Prostate Cancer

Men in small study took capsules equivalent to brewed beverage,, FRIDAY, June 19 (HealthDay News) -- The active compounds in green tea might slow the progression of prostate cancer, the results of a small study suggest. The study included 26 men, 41 to 72 years old, who had prostate...

Photos: Soccer Hall of Famer Marcelo Balboa Encourages Men to 'Team Up Against Prostate Cancer'

New Campaign Launches on Father's Day to Encourage Men & Their Families to Take an Active Role in Protecting their Prostate Health NEW YORK, June 19 /PRNewswire/ -- The son of a professional player and coach, soccer runs in Marcelo Balboa's family, but like many others, so does prost...

New Prostate Cancer Biomarker Discovered

Finding also might apply in other types of cancer, researcher says THURSDAY, June 18 (HealthDay News) -- A new marker for advanced prostate cancer and metastasis, or spread, of the disease has been identified by U.S. researchers. Their analysis of prostate tissue from men with local...

Organization Announces End Prostate Cancer Tour

ZERO - The Project to End Prostate Cancer Brings Awareness Across Country; Partnership with Depend Helps Raise Money for the Cause WASHINGTON, June 17 /PRNewswire-USNewswire/ -- Zero prostate cancer deaths. Zero prostate cancer cases and for those with prostate cancer, it means a zero PSA....

Dad Offers Personal Father's Day Message on Importance of Prostate Cancer Screenings

Prostate cancer is more common in men than breast cancer is in women. Joel Stern learned of his prostate cancer through a regular screening, which doctors recommend should start at age 50. "Thanks to the early detection of my cancer, I had a wider range of treatment options," Stern said...

Consumer Reports 'Best Buy Drug' for Enlarged Prostate Could Save Consumers Nearly $3,000 a Year

Flomax Is Case Study of How Costly Drugs Drive Up Health Costs YONKERS, N.Y., June 15 /PRNewswire-USNewswire/ -- According to a new report by Consumer Reports Best Buy Drugs, the generic drug doxazosin is as safe and effective as the widely advertised drug Flomax for treating the s...

New approach for treating recurrent prostate cancer on the horizon

TORONTOA new study shows that an alpha-particle emitting radiopeptideradioactive material bound to a synthetic peptide, a component of proteinis effective for treating prostate cancer in mice, according to researchers at SNM's 56th Annual Meeting in Toronto. The results could eventually result in ...

Decision tool for prostate cancer patients helps men customize treatment in anxious time

An online decision tool created in part by a graduate student at the University of California Irvine helps men diagnosed with prostate cancer sort through an intimidating flurry of possible treatments and customize treatment plans of their own, according to a study in the current issue of Interfa...

Kimberly-Clark Teams Up With Sports Legends to Launch 'The Depend Campaign to End Prostate Cancer'

Brand unveils four-month awareness campaign featuring Len Dawson, Ken Griffey Sr., Jim Colbert, Joe Cortez and Rod Woodson to support partnership with ZERO - The Project to End Prostate Cancer DALLAS, June 15 /PRNewswire-FirstCall/ -- With prostate cancer affecting a staggering one in...

Longer Hormone Treatment May Improve Prostate Cancer Outlook

European and U.S. studies find similar results WEDNESDAY, June 10 (HealthDay News) -- Men with moderately advanced prostate cancer who get hormone-blocking drugs after radiation therapy do better when the drug treatment is continued for two or more years after an initial six-month reg...

Hormone therapy may confer more aggressive properties to prostate tumors

Hormone therapy is often given to patients with advanced prostate cancer. While it is true that the treatment prevents growth of the tumour, it also changes its properties. Some of these changes may result in the tumour becoming more aggressive and more liable to form metastases. This is one of th...

Effective over-the-counter prostate cancer test kit likely in next few years

An over-the-counter prostate cancer test kit could be coming to a pharmacy near you, thanks to the collaborative work of a University of Central Florida chemist and M.D. Anderson Cancer Center Orlando researchers. UCF's Qun "Treen" Huo and M.D. Anderson-Orlando's Dr. Cheryl Baker and Jimmie Co...

Diet may reduce risk of prostate cancer

Sydney, AustraliaJune 3, 2009A new review published in the Journal of Human Nutrition and Dietetics assessed whether certain modifications in diet have a beneficial effect on the prevention of prostate cancer. Results suggest that a diet low in fat and red meat and high in fruits and vegetables ...

Gene Test Helps Detect Prostate Cancer

New screen boosts accuracy of standard PSA test, study shows SUNDAY, May 31 (HealthDay News) -- A new blood test greatly reduces false-positive results in prostate cancer screenings and, when used in combination with a prostate-specific antigen (PSA) test, could prevent many unnecessar...

New blood test greatly reduces false-positives in prostate cancer screening

ORLANDO, Fla.--A new blood test used in combination with a conventional prostate-specific antigen (PSA) screening sharply increases the accuracy of prostate cancer diagnosis, and could eliminate tens of thousands of unneeded, painful, and costly prostate biopsies annually, according to a study led...

Poniard Pharmaceuticals Announces Positive Efficacy and Safety Data From Phase 2 Clinical Trial of Picoplatin in Men With Metastatic Prostate Cancer

- New Progression-Free Survival Data To Be Presented at 2009 ASCO Annual Meeting Support Further Clinical Development of Picoplatin in Combination with Docetaxel/Prednisone as First-Line Therapy for Metastatic Castration-Resistant Prostate Cancer - - Poniard Management Team to Host Analyst an...

Why some prostate cancer returns

ORLANDO The majority of men who receive one of the standard treatments for localized prostate cancer surgery or radiation therapy have an excellent outcome. But for the small group whose prostate cancer returns, a new study offers insight as to why treatment isn't effective. The study ...

Enlarged Prostate and Erectile Dysfunction Are Subjects of Free Men's Health Seminar

TUCSON, Ariz., May 27 /PRNewswire/ -- Dr. Peter Burrows from the Arizona Center-Vasectomy/Urology, a specialist in men's health issues, will be leading a free Men's Health Seminar on Saturday June 6th. The program, to be held at 8:30 AM at El Dorado Hospital, will explain the latest treatment...

Predicting higher risk for prostate cancer diagnosis

High-grade prostatic intraepithelial neoplasia (HGPIN) carries a high predictive value for future diagnosis of prostate cancer. Research published in the open access journal BMC Urology has shown that 41.8% of patients whose extended core biopsy led to an initial diagnosis of HGPIN were subseque...

Carbohydrate restriction may slow prostate tumor growth

DURHAM, N.C. -- Restricting carbohydrates, regardless of weight loss, appears to slow the growth of prostate tumors, according to an animal study being published this week by researchers in the Duke Prostate Center. "Previous work here and elsewhere has shown that a diet light in carbohydrates ...

Advanced Prostate Cancer Deadlier in Younger Men

Patients under 44 were three times more likely to die, study finds FRIDAY, May 22 (HealthDay News) -- Younger men diagnosed with advanced prostate cancer don't live as long as older men facing the same diagnosis, a new study finds. "Overall, young men with prostate cancer do quite ...